Campbell & CO Investment Adviser LLC Grows Stock Holdings in Progyny, Inc. (NASDAQ:PGNY)

Campbell & CO Investment Adviser LLC raised its holdings in Progyny, Inc. (NASDAQ:PGNYFree Report) by 29.4% in the 3rd quarter, HoldingsChannel reports. The fund owned 31,671 shares of the company’s stock after acquiring an additional 7,193 shares during the period. Campbell & CO Investment Adviser LLC’s holdings in Progyny were worth $1,077,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Headlands Technologies LLC acquired a new position in Progyny in the 2nd quarter valued at $41,000. Rockefeller Capital Management L.P. raised its holdings in Progyny by 3,119.2% in the 4th quarter. Rockefeller Capital Management L.P. now owns 1,674 shares of the company’s stock valued at $50,000 after acquiring an additional 1,622 shares during the last quarter. Lazard Asset Management LLC grew its stake in shares of Progyny by 45.2% during the 4th quarter. Lazard Asset Management LLC now owns 1,763 shares of the company’s stock valued at $54,000 after buying an additional 549 shares during the period. International Assets Investment Management LLC purchased a new stake in shares of Progyny during the 3rd quarter valued at $58,000. Finally, State of Wyoming grew its stake in shares of Progyny by 136.2% during the 2nd quarter. State of Wyoming now owns 1,717 shares of the company’s stock valued at $68,000 after buying an additional 990 shares during the period. 94.93% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on the stock. KeyCorp lowered their price objective on shares of Progyny from $50.00 to $45.00 and set an “overweight” rating for the company in a research note on Wednesday, November 8th. Truist Financial lowered their price objective on shares of Progyny from $52.00 to $47.00 and set a “buy” rating for the company in a research note on Wednesday, November 8th. Finally, Barclays started coverage on shares of Progyny in a research note on Wednesday, January 3rd. They set an “overweight” rating and a $48.00 price objective for the company. Eight investment analysts have rated the stock with a buy rating, According to MarketBeat.com, Progyny has a consensus rating of “Buy” and an average price target of $48.56.

Read Our Latest Stock Report on Progyny

Progyny Trading Up 0.2 %

Shares of Progyny stock opened at $40.44 on Friday. The company has a fifty day moving average price of $37.54 and a 200 day moving average price of $35.87. Progyny, Inc. has a twelve month low of $29.44 and a twelve month high of $44.95. The stock has a market cap of $3.88 billion, a price-to-earnings ratio of 77.77, a price-to-earnings-growth ratio of 1.41 and a beta of 1.51.

Progyny (NASDAQ:PGNYGet Free Report) last announced its quarterly earnings results on Tuesday, November 7th. The company reported $0.16 earnings per share for the quarter, topping analysts’ consensus estimates of $0.11 by $0.05. The firm had revenue of $280.90 million during the quarter, compared to analysts’ expectations of $271.20 million. Progyny had a net margin of 5.03% and a return on equity of 11.64%. The firm’s revenue was up 36.8% on a year-over-year basis. During the same period in the prior year, the company earned $0.13 EPS. Analysts forecast that Progyny, Inc. will post 0.57 earnings per share for the current year.

Insider Buying and Selling at Progyny

In other Progyny news, President Michael E. Sturmer sold 12,696 shares of the company’s stock in a transaction dated Friday, December 1st. The shares were sold at an average price of $34.13, for a total value of $433,314.48. Following the completion of the transaction, the president now directly owns 173,806 shares of the company’s stock, valued at approximately $5,931,998.78. The transaction was disclosed in a filing with the SEC, which is accessible through this link. In other Progyny news, President Michael E. Sturmer sold 6,395 shares of the company’s stock in a transaction dated Tuesday, January 2nd. The shares were sold at an average price of $36.81, for a total value of $235,399.95. Following the completion of the transaction, the president now directly owns 167,187 shares of the company’s stock, valued at approximately $6,154,153.47. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, President Michael E. Sturmer sold 12,696 shares of the company’s stock in a transaction dated Friday, December 1st. The shares were sold at an average price of $34.13, for a total transaction of $433,314.48. Following the completion of the transaction, the president now directly owns 173,806 shares of the company’s stock, valued at $5,931,998.78. The disclosure for this sale can be found here. Insiders sold a total of 322,369 shares of company stock valued at $12,052,491 in the last ninety days. Insiders own 14.30% of the company’s stock.

About Progyny

(Free Report)

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.

Featured Stories

Want to see what other hedge funds are holding PGNY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Progyny, Inc. (NASDAQ:PGNYFree Report).

Institutional Ownership by Quarter for Progyny (NASDAQ:PGNY)

Receive News & Ratings for Progyny Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Progyny and related companies with MarketBeat.com's FREE daily email newsletter.